The company expanded its 3D printing capacity by investing in eight GE Arcam EMB 3D printers to address the orthopedic needs of China's aging population.
Despite the impact of COVID, the company forged ahead with its priorities, including expanding its U.S. business and accelerating its innovation pipeline.
The company's orthopedic sales declined -49% in 2Q20 but recovered significantly from -80% declines in April. Integra expects improvement through 2H20.
The company's sales improved throughout 2Q20 but exited June with declines in the mid-teens. Orthofix remains cautious about second-half unpredictability.
The company's sales accelerated through 2Q20 and grew in the high single digits in July, but it cautioned that the new patient pipeline could slow in 2H20.